Invitron

Invitron is a specialized biotechnology company based in the United Kingdom that focuses on the development and manufacture of high-sensitivity luminescence-based immunoassays. Founded in 1989, the company provides advanced diagnostic tools for clinical research and laboratory medicine, with a particular emphasis on metabolic markers and endocrinology. Their product portfolio includes specialized assays for proinsulin, insulin, C-peptide, and GLP-1, designed to offer superior sensitivity compared to conventional methods. Invitron's technology is widely used in clinical trials and academic research to monitor therapeutic efficacy and disease progression in conditions such as diabetes and growth disorders. The company operates as a private entity, serving a global client base of researchers and diagnostic professionals.